MeSH Browser

MeSH Heading: Antineoplastic Combined Chemotherapy Protocols
Tree Number(s): E02.183.750.500; E02.319.077.500; E02.319.310.037
Unique ID: D000971
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D000971
Annotation: coordinate IM with specific antineoplastic agents (IM or NIM)
Scope Note: The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form.
Entry Term(s): Anticancer Drug Combinations; Antineoplastic Agents, Combined; Antineoplastic Chemotherapy Protocols; Antineoplastic Combined Chemotherapy Regimens; Antineoplastic Drug Combinations; Cancer Chemotherapy Protocols; Chemotherapy Protocols, Antineoplastic; Combined Antineoplastic Agents; Drug Combinations, Antineoplastic
NLM Classification #: QZ 267
Previous Indexing: Drug Therapy, Combination (1974-1983)
Public MeSH Note: 2002; see ANTINEOPLASTIC AGENTS, COMBINED (1984-2001)
History Note: 2002(1984)
Date Established: 1984/01/01
Date of Entry: 1983/06/17
Revision Date: 2015/06/23

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

analysis (AN)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Antineoplastic Combined Chemotherapy Protocols MeSH Descriptor Data 2025